DE60224203D1 - Dithiazolverbindungen, matrix-metalloprotease-inhibitoren und zubereitungen für die äusserliche anwendung auf der haut - Google Patents

Dithiazolverbindungen, matrix-metalloprotease-inhibitoren und zubereitungen für die äusserliche anwendung auf der haut

Info

Publication number
DE60224203D1
DE60224203D1 DE60224203T DE60224203T DE60224203D1 DE 60224203 D1 DE60224203 D1 DE 60224203D1 DE 60224203 T DE60224203 T DE 60224203T DE 60224203 T DE60224203 T DE 60224203T DE 60224203 D1 DE60224203 D1 DE 60224203D1
Authority
DE
Germany
Prior art keywords
dithiazone
preparations
skin
compounds
matrix metalloprotease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60224203T
Other languages
English (en)
Other versions
DE60224203T2 (de
Inventor
Takuya Hiruma
Koji Kobayashi
Shinji Inomata
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shiseido Co Ltd
Original Assignee
Shiseido Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shiseido Co Ltd filed Critical Shiseido Co Ltd
Publication of DE60224203D1 publication Critical patent/DE60224203D1/de
Application granted granted Critical
Publication of DE60224203T2 publication Critical patent/DE60224203T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Birds (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE60224203T 2001-08-28 2002-08-28 DITHIAZOLVERBINDUNGEN, MATRIX-METALLOPROTEASE-INHIBITOREN UND ZUBEREITUNGEN FÜR DIE ÄUßERLICHE ANWENDUNG AUF DER HAUT Expired - Lifetime DE60224203T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2001258066A JP4825375B2 (ja) 2001-08-28 2001-08-28 ジチアゾール化合物及びマトリックスメタロプロテアーゼ活性阻害剤、皮膚外用剤
JP2001258066 2001-08-28
PCT/JP2002/008649 WO2003020711A1 (fr) 2001-08-28 2002-08-28 Composes dithiazole, inhibiteurs de metalloprotease matricielle et preparations a usage externe pour la peau

Publications (2)

Publication Number Publication Date
DE60224203D1 true DE60224203D1 (de) 2008-01-31
DE60224203T2 DE60224203T2 (de) 2008-12-04

Family

ID=19085645

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60224203T Expired - Lifetime DE60224203T2 (de) 2001-08-28 2002-08-28 DITHIAZOLVERBINDUNGEN, MATRIX-METALLOPROTEASE-INHIBITOREN UND ZUBEREITUNGEN FÜR DIE ÄUßERLICHE ANWENDUNG AUF DER HAUT

Country Status (7)

Country Link
US (1) US7348017B2 (de)
EP (1) EP1422224B1 (de)
JP (1) JP4825375B2 (de)
KR (1) KR100911092B1 (de)
CN (1) CN1319957C (de)
DE (1) DE60224203T2 (de)
WO (1) WO2003020711A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRE20010042A1 (it) * 2001-04-24 2002-10-24 Corghi Spa Dispositivo sollevatore per macchine smontagomme
WO2004091486A2 (en) * 2003-04-15 2004-10-28 Wellstat Therapeutics Corporation Compounds for the treatment of metabolic disorders
CA2561741C (en) * 2004-04-05 2016-09-27 Alnylam Pharmaceuticals, Inc. Processes and reagents for oligonucleotide synthesis and purification
EP1760071A4 (de) * 2004-06-23 2008-03-05 Ono Pharmaceutical Co Verbindung mit s1p-rezeptorbindungsfähigkeit und verwendung dafür
EP1807076A4 (de) * 2004-10-29 2010-06-02 Merck Sharp & Dohme N-(pyridin-3-yl)-2-phenylbutanamide als androgenrezeptormodulatoren
TW200800872A (en) * 2005-09-07 2008-01-01 Plexxikon Inc PPAR active compounds
CN101454270A (zh) * 2006-06-02 2009-06-10 帝斯曼知识产权资产管理有限公司 制备羟基-芳族树脂的方法、羟基-芳族树脂及其改性
KR101057485B1 (ko) * 2008-08-04 2011-08-17 서울대학교산학협력단 1,2-디티올티온 유도체를 함유하는 엘엑스알-알파 과다발현으로 인한 질병의 예방 및 치료용 약학 조성물
US8546566B2 (en) 2010-10-12 2013-10-01 Boehringer Ingelheim International Gmbh Process for manufacturing dihydropteridinones and intermediates thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3753908A (en) 1971-08-30 1973-08-21 Chevron Res Oxidation inhibited lubricating oil compositions with extreme pressure properties
DE2228364C3 (de) * 1972-06-10 1982-03-18 Bergwerksverband Gmbh, 4300 Essen 3-Acylamino-1,2,4-dithiazolin-5-thione (Acylxanthanwasserstoff).
EP0822186B1 (de) * 1994-01-20 2000-03-15 British Biotech Pharmaceuticals Limited L-Tertiär-leucin-2-pyridylamid
US5677282A (en) * 1995-06-07 1997-10-14 Proscript, Inc. Amino acid amides of 1,3,4-thiadiazoles as matrix metalloproteinase
JP2000509039A (ja) * 1996-04-23 2000-07-18 ファルマシア・アンド・アップジョン・カンパニー マトリックスメタロプロテイナーゼ・インヒビターとして有用なチアジアゾリル（チオ）尿素
EP1021424B1 (de) * 1996-06-21 2003-02-26 PHARMACIA & UPJOHN COMPANY Mmp-hemmende thiadiazolylamide
ATE226193T1 (de) 1996-08-28 2002-11-15 Procter & Gamble Substituierte zyklische amine als metalloproteaseinhibitoren
US6096881A (en) * 1997-05-30 2000-08-01 Hybridon, Inc. Sulfur transfer reagents for oligonucleotide synthesis
WO1999032111A1 (en) * 1997-12-22 1999-07-01 Bayer Corporation INHIBITION OF p38 KINASE ACTIVITY USING SUBSTITUTED HETEROCYCLIC UREAS

Also Published As

Publication number Publication date
JP4825375B2 (ja) 2011-11-30
WO2003020711A1 (fr) 2003-03-13
KR20040032149A (ko) 2004-04-14
CN1549809A (zh) 2004-11-24
KR100911092B1 (ko) 2009-08-06
JP2003064065A (ja) 2003-03-05
DE60224203T2 (de) 2008-12-04
EP1422224A4 (de) 2005-11-09
EP1422224A1 (de) 2004-05-26
US7348017B2 (en) 2008-03-25
CN1319957C (zh) 2007-06-06
US20040236111A1 (en) 2004-11-25
EP1422224B1 (de) 2007-12-19

Similar Documents

Publication Publication Date Title
HK1223040A1 (zh) 局部皮膚護理組合物
DE60104901D1 (de) Hydroverfahrenskatalysator und dessen anwendung
DE60141543D1 (de) Spritzenzylinder und Halter
DE60221143D1 (de) Brusteinlage enthaltend hautpflegemittel
PT1307457E (pt) Compostos heterociclicos sua preparacao e utilizacao como medicamentos noemadamente como antibacterianos
DE60106275D1 (de) Dermatologisches mittel
DE60212527D1 (de) Injektoranordnung zum Verhindern von anschliessendem Heraustropfen, sowie Kolbenstange und Dichtungskörper für die Injektoranordnung
DE60239558D1 (de) Kombinationen für die behandlung von immun-entzündlichen erkrankungen
ATE508731T1 (de) Haarbehandlungszusammensetzungen, die haarvolumen verleihen und die druckemfpindliche silikon- kleber enthalten
DE60127548D1 (de) Äusserlich anzuwendende zubereitungen für die haut zur unterdrückung der sebum-sekretion
DE60132676D1 (de) Hydraulische scherenvorrichtung
DE50209476D1 (de) Revitalisierender wirkkomplex für die haut
DE60232673D1 (de) Zusammensetzungen, die combretastatin und krebsbekämpfendes mittel enthalten
ATE478653T1 (de) Behandlungsmittel für die nasse haut
DE60333391D1 (de) Bleichmittel, hautpräparat zur äusseren anwendung und kosmetikum
DE60113000D1 (de) Heckklappenaussenhaut
DE60224203D1 (de) Dithiazolverbindungen, matrix-metalloprotease-inhibitoren und zubereitungen für die äusserliche anwendung auf der haut
DE60223576D1 (de) Hautbehandlungszusammensetzung
DE60335019D1 (de) Topische hautpräparate
DE60222664D1 (de) Hautbehandlungsmittel
DE60209220D1 (de) Haarpflegemittel
DE60016867D1 (de) Topische Zusammensetzung für die Haut und deren Anwendung
DE69934484D1 (de) Flüssiges antimikrobielles feuchthaltendes mittel für die haut
NO20030950D0 (no) Verktöy for utskiftbar trykk- og temperaturverktöy
IS7902A (is) Blettaeyðandi samsetning fyrir húðumhirðu

Legal Events

Date Code Title Description
8364 No opposition during term of opposition